Vaccines Market

Vaccines Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

141

Base Year:

2022

Apr - 2022

Format:

Report Code:

VMR-1508

Segments Covered

By Technology (excluding COVID 19 vaccines) Conjugate vaccines, Inactivated & Subunit vaccines, Live Attenuated vaccines, Recombinant vaccines, Toxoid vaccines, Viral vector vaccines
By Technology (including COVID 19 vaccines) mRNA vaccines, Viral Vector vaccines, Others
By Type Monovalent vaccines, Multivalent vaccines
By Disease Indication Influenza, Pneumococcal diseases, Combination vaccines, HPV, Herpes Zoster, Meningococcal diseases, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, COVID 19, Others
By Route of Administration Intramuscular & Subcutaneous administration, Oral administration, Others
By End-user Pediatric vaccines, Adult vaccines
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 43.80 Billion
Revenue 2030:	USD 90.52 Billion
Revenue CAGR (2023 - 2030):	9.50%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Vaccines Market - Segment Analysis
1. Overview
2. Global Vaccines Market, 2016 - 2028 (USD Million)
3. Global Vaccines Market - by Technology (excluding COVID 19 vaccines)
  1. By Conjugate vaccines
  2. By Inactivated & Subunit vaccines
  3. By Live Attenuated vaccines
  4. By Recombinant vaccines
  5. By Toxoid vaccines
  6. By Viral vector vaccines
4. Global Vaccines Market - by Technology (including COVID 19 vaccines)
  1. By mRNA vaccines
  2. By Viral Vector vaccines
  3. By Others
5. Global Vaccines Market - by Type
  1. By Monovalent vaccines
  2. By Multivalent vaccines
6. Global Vaccines Market - by Disease Indication
  1. By Influenza
  2. By Pneumococcal diseases
  3. By Combination vaccines
  4. By HPV
  5. By Herpes Zoster
  6. By Meningococcal diseases
  7. By Rotavirus
  8. By MMR
  9. By Varicella
  10. By Hepatitis
  11. By DTP
  12. By Polio
  13. By COVID 19
  14. By Others
7. Global Vaccines Market - by Route of Administration
  1. By Intramuscular & Subcutaneous administration
  2. By Oral administration
  3. By Others
8. Global Vaccines Market - by End-user
  1. By Pediatric vaccines
  2. By Adult vaccines
9. Global Vaccines Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
10. Market comparative analysis
North America Vaccines Market - Segment Analysis
1. Overview
2. North America Vaccines Market, 2016 - 2028 (USD Million)
3. North America Vaccines Market, by Technology (excluding COVID 19 vaccines)
  1. By Conjugate vaccines
  2. By Inactivated & Subunit vaccines
  3. By Live Attenuated vaccines
  4. By Recombinant vaccines
  5. By Toxoid vaccines
  6. By Viral vector vaccines
4. North America Vaccines Market, by Technology (including COVID 19 vaccines)
  1. By mRNA vaccines
  2. By Viral Vector vaccines
  3. By Others
5. North America Vaccines Market, by Type
  1. By Monovalent vaccines
  2. By Multivalent vaccines
6. North America Vaccines Market, by Disease Indication
  1. By Influenza
  2. By Pneumococcal diseases
  3. By Combination vaccines
  4. By HPV
  5. By Herpes Zoster
  6. By Meningococcal diseases
  7. By Rotavirus
  8. By MMR
  9. By Varicella
  10. By Hepatitis
  11. By DTP
  12. By Polio
  13. By COVID 19
  14. By Others
7. North America Vaccines Market, by Route of Administration
  1. By Intramuscular & Subcutaneous administration
  2. By Oral administration
  3. By Others
8. North America Vaccines Market, by End-user
  1. By Pediatric vaccines
  2. By Adult vaccines
9. North America Vaccines Market, by Country
  1. U.S.
    1. U.S. Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. U.S. Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. U.S. Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. U.S. Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. U.S. Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. U.S. Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  2. Canada
    1. Canada Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. Canada Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. Canada Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. Canada Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. Canada Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. Canada Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  3. Mexico
    1. Mexico Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. Mexico Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. Mexico Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. Mexico Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. Mexico Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. Mexico Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
Europe Vaccines Market - Segment Analysis
1. Overview
2. Europe Vaccines Market, 2016 - 2028 (USD Million)
3. Europe Vaccines Market, by Technology (excluding COVID 19 vaccines)
  1. By Conjugate vaccines
  2. By Inactivated & Subunit vaccines
  3. By Live Attenuated vaccines
  4. By Recombinant vaccines
  5. By Toxoid vaccines
  6. By Viral vector vaccines
4. Europe Vaccines Market, by Technology (including COVID 19 vaccines)
  1. By mRNA vaccines
  2. By Viral Vector vaccines
  3. By Others
5. Europe Vaccines Market, by Type
  1. By Monovalent vaccines
  2. By Multivalent vaccines
6. Europe Vaccines Market, by Disease Indication
  1. By Influenza
  2. By Pneumococcal diseases
  3. By Combination vaccines
  4. By HPV
  5. By Herpes Zoster
  6. By Meningococcal diseases
  7. By Rotavirus
  8. By MMR
  9. By Varicella
  10. By Hepatitis
  11. By DTP
  12. By Polio
  13. By COVID 19
  14. By Others
7. Europe Vaccines Market, by Route of Administration
  1. By Intramuscular & Subcutaneous administration
  2. By Oral administration
  3. By Others
8. Europe Vaccines Market, by End-user
  1. By Pediatric vaccines
  2. By Adult vaccines
9. Europe Vaccines Market, by Country
  1. Germany
    1. Germany Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. Germany Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. Germany Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. Germany Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. Germany Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. Germany Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  2. UK
    1. UK Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. UK Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. UK Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. UK Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. UK Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. UK Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  3. France
    1. France Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. France Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. France Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. France Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. France Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. France Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  4. Spain
    1. Spain Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. Spain Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. Spain Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. Spain Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. Spain Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. Spain Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  5. Italy
    1. Italy Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. Italy Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. Italy Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. Italy Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. Italy Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. Italy Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  6. BENELUX
    1. BENELUX Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. BENELUX Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. BENELUX Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. BENELUX Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. BENELUX Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. BENELUX Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  7. Rest of Europe
    1. Rest Of Europe Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. Rest Of Europe Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. Rest Of Europe Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. Rest Of Europe Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. Rest Of Europe Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. Rest Of Europe Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
Asia Pacific Vaccines Market - Segment Analysis
1. Overview
2. Asia Pacific Vaccines Market, 2016 - 2028 (USD Million)
3. Asia Pacific Vaccines Market, by Technology (excluding COVID 19 vaccines)
  1. By Conjugate vaccines
  2. By Inactivated & Subunit vaccines
  3. By Live Attenuated vaccines
  4. By Recombinant vaccines
  5. By Toxoid vaccines
  6. By Viral vector vaccines
4. Asia Pacific Vaccines Market, by Technology (including COVID 19 vaccines)
  1. By mRNA vaccines
  2. By Viral Vector vaccines
  3. By Others
5. Asia Pacific Vaccines Market, by Type
  1. By Monovalent vaccines
  2. By Multivalent vaccines
6. Asia Pacific Vaccines Market, by Disease Indication
  1. By Influenza
  2. By Pneumococcal diseases
  3. By Combination vaccines
  4. By HPV
  5. By Herpes Zoster
  6. By Meningococcal diseases
  7. By Rotavirus
  8. By MMR
  9. By Varicella
  10. By Hepatitis
  11. By DTP
  12. By Polio
  13. By COVID 19
  14. By Others
7. Asia Pacific Vaccines Market, by Route of Administration
  1. By Intramuscular & Subcutaneous administration
  2. By Oral administration
  3. By Others
8. Asia Pacific Vaccines Market, by End-user
  1. By Pediatric vaccines
  2. By Adult vaccines
9. Asia Pacific Vaccines Market, by Country
  1. China
    1. China Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. China Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. China Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. China Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. China Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. China Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  2. Japan
    1. Japan Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. Japan Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. Japan Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. Japan Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. Japan Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. Japan Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  3. India
    1. India Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. India Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. India Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. India Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. India Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. India Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  4. South Korea
    1. South Korea Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. South Korea Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. South Korea Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. South Korea Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. South Korea Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. South Korea Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  5. South East Asia
    1. South East Asia Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. South East Asia Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. South East Asia Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. South East Asia Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. South East Asia Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. South East Asia Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. Rest of Asia Pacific Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. Rest of Asia Pacific Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. Rest of Asia Pacific Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. Rest of Asia Pacific Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. Rest of Asia Pacific Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
Latin America Vaccines Market - Segment Analysis
1. Overview
2. Latin America Vaccines Market, 2016 - 2028 (USD Million)
3. Latin America Vaccines Market, by Technology (excluding COVID 19 vaccines)
  1. By Conjugate vaccines
  2. By Inactivated & Subunit vaccines
  3. By Live Attenuated vaccines
  4. By Recombinant vaccines
  5. By Toxoid vaccines
  6. By Viral vector vaccines
4. Latin America Vaccines Market, by Technology (including COVID 19 vaccines)
  1. By mRNA vaccines
  2. By Viral Vector vaccines
  3. By Others
5. Latin America Vaccines Market, by Type
  1. By Monovalent vaccines
  2. By Multivalent vaccines
6. Latin America Vaccines Market, by Disease Indication
  1. By Influenza
  2. By Pneumococcal diseases
  3. By Combination vaccines
  4. By HPV
  5. By Herpes Zoster
  6. By Meningococcal diseases
  7. By Rotavirus
  8. By MMR
  9. By Varicella
  10. By Hepatitis
  11. By DTP
  12. By Polio
  13. By COVID 19
  14. By Others
7. Latin America Vaccines Market, by Route of Administration
  1. By Intramuscular & Subcutaneous administration
  2. By Oral administration
  3. By Others
8. Latin America Vaccines Market, by End-user
  1. By Pediatric vaccines
  2. By Adult vaccines
9. Latin America Vaccines Market, by Country
  1. Brazil
    1. Brazil Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. Brazil Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. Brazil Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. Brazil Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. Brazil Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. Brazil Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  2. Argentina
    1. Argentina Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. Argentina Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. Argentina Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. Argentina Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. Argentina Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. Argentina Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  3. Rest of Latin America
    1. Rest of Latin America Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. Rest of Latin America Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. Rest of Latin America Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. Rest of Latin America Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. Rest of Latin America Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. Rest of Latin America Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
Middle East & Africa Vaccines Market - Segment Analysis
1. Overview
2. Middle East & Africa Vaccines Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Vaccines Market, by Technology (excluding COVID 19 vaccines)
  1. By Conjugate vaccines
  2. By Inactivated & Subunit vaccines
  3. By Live Attenuated vaccines
  4. By Recombinant vaccines
  5. By Toxoid vaccines
  6. By Viral vector vaccines
4. Middle East & Africa Vaccines Market, by Technology (including COVID 19 vaccines)
  1. By mRNA vaccines
  2. By Viral Vector vaccines
  3. By Others
5. Middle East & Africa Vaccines Market, by Type
  1. By Monovalent vaccines
  2. By Multivalent vaccines
6. Middle East & Africa Vaccines Market, by Disease Indication
  1. By Influenza
  2. By Pneumococcal diseases
  3. By Combination vaccines
  4. By HPV
  5. By Herpes Zoster
  6. By Meningococcal diseases
  7. By Rotavirus
  8. By MMR
  9. By Varicella
  10. By Hepatitis
  11. By DTP
  12. By Polio
  13. By COVID 19
  14. By Others
7. Middle East & Africa Vaccines Market, by Route of Administration
  1. By Intramuscular & Subcutaneous administration
  2. By Oral administration
  3. By Others
8. Middle East & Africa Vaccines Market, by End-user
  1. By Pediatric vaccines
  2. By Adult vaccines
9. Middle East & Africa Vaccines Market, by Country
  1. GCC Countries
    1. GCC Countries Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. GCC Countries Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. GCC Countries Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. GCC Countries Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. GCC Countries Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. GCC Countries Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  2. South Africa
    1. South Africa Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. South Africa Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. South Africa Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. South Africa Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. South Africa Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. South Africa Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Vaccines Market, By Technology (excluding COVID 19 vaccines)
      1. By Conjugate vaccines
      2. By Inactivated & Subunit vaccines
      3. By Live Attenuated vaccines
      4. By Recombinant vaccines
      5. By Toxoid vaccines
      6. By Viral vector vaccines
    2. Rest of Middle East & Africa Vaccines Market, By Technology (including COVID 19 vaccines)
      1. By mRNA vaccines
      2. By Viral Vector vaccines
      3. By Others
    3. Rest of Middle East & Africa Vaccines Market, By Type
      1. By Monovalent vaccines
      2. By Multivalent vaccines
    4. Rest of Middle East & Africa Vaccines Market, By Disease Indication
      1. By Influenza
      2. By Pneumococcal diseases
      3. By Combination vaccines
      4. By HPV
      5. By Herpes Zoster
      6. By Meningococcal diseases
      7. By Rotavirus
      8. By MMR
      9. By Varicella
      10. By Hepatitis
      11. By DTP
      12. By Polio
      13. By COVID 19
      14. By Others
    5. Rest of Middle East & Africa Vaccines Market, By Route of Administration
      1. By Intramuscular & Subcutaneous administration
      2. By Oral administration
      3. By Others
    6. Rest of Middle East & Africa Vaccines Market, By End-user
      1. By Pediatric vaccines
      2. By Adult vaccines
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. GlaxoSmithKline plc (UK)
2. Merck & Co. Inc. (US)
3. Pfizer Inc. (US)
4. Sanofi SA (France)
5. CSL Limited (Australia)
6. Emergent BioSolutions Inc. (US)
7. Johnson & Johnson (US)
8. AstraZeneca plc (UK)
9. Serum Institute of India Pvt. Ltd. (India)
10. Bavarian Nordic A/S (Denmark)
11. Mitsubishi Tanabe Pharma Corporation (Japan)
12. Daiichi Sankyo Company
13. Limited (Japan)
14. Panacea Biotec Ltd. (India)
15. Biological E Limited (India)
16. Bharat Biotech Ltd. (India)
17. Novavax Inc. (US)
18. FSUE NPO Microgen (Russia)
19. Sinovac Biotech Ltd. (China) Inc.pta Vaccine Limited (Bangladesh)
20. Valneva SE (France)
21. VBI Vaccines (US)
22. PT Bio Farma (Persero) (Indonesia)
23. Inovio Pharmaceuticals Inc. (US)
24. Chongqing Zhifei Biological Products Co. Ltd. (China)
25. Indian Immunologicals Limited (India).
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Vaccines in terms of revenue?

The global Vaccines valued at USD 43.80 Billion in 2022 and is expected to reach USD 90.52 Billion in 2030 growing at a CAGR of 9.50%.

Which are the prominent players in the market?

The prominent players in the market are GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Pfizer Inc. (US), Sanofi SA (France), CSL Limited (Australia), Emergent BioSolutions Inc. (US), Johnson & Johnson (US), AstraZeneca plc (UK), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic A/S (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo Company, Limited (Japan), Panacea Biotec, Ltd. (India), Biological E Limited (India), Bharat Biotech Ltd. (India), Novavax Inc. (US), FSUE NPO Microgen (Russia), Sinovac Biotech, Ltd. (China), Incepta Vaccine Limited (Bangladesh), Valneva SE (France), VBI Vaccines (US), PT Bio Farma (Persero) (Indonesia), Inovio Pharmaceuticals Inc. (US), Chongqing Zhifei Biological Products Co., Ltd. (China), Indian Immunologicals Limited (India)..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 9.50% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Vaccines include
- Growing prevalence of emerging and re-emerging infectious diseases

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Vaccines in 2022.

Vaccines Market

Vaccines Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Vaccines in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Vaccines Market

Vaccines Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Vaccines in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Vaccines Market

Vantage Point Interactive Dashboard